Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Podrobná bibliografie
Hlavní autoři:	Hennekens, C, Buring, J, Sandercock, P, Collins, R, Peto, R
Médium:	Journal article
Jazyk:	English
Vydáno:	1989

Podobné jednotky

Aspirin and stroke.
Autor: Buring, J, a další
Vydáno: (1990)

ASPIRIN USE AND CHRONIC DISEASES
Autor: Hennekens, C, a další
Vydáno: (1990)

Aspirin in ischemic heart disease.
Autor: Hennekens, C, a další
Vydáno: (1992)

Low-dose aspirin for migraine prophylaxis.
Autor: Buring, J, a další
Vydáno: (1990)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Autor: Baigent, C, a další
Vydáno: (2009)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
Autor: Hennekens, C, a další
Vydáno: (1996)

Antiplatelet agents in stroke prevention.
Autor: Peto, R
Vydáno: (1988)

Aspirin in the primary prevention of vascular disease Reply
Autor: Baigent, C, a další
Vydáno: (2009)

Aspirin in the primary prevention of vascular disease Reply
Autor: Baigent, C, a další
Vydáno: (2009)

Prevention. Aspirin in primary prevention--good news and bad news.
Autor: Hennekens, C, a další
Vydáno: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
Autor: Hennekens, C, a další
Vydáno: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
Autor: Collins, R, a další
Vydáno: (1994)

TRIALS OF ANTIPLATELET THERAPY - REPLY
Autor: Baigent, C, a další
Vydáno: (1994)

Polypills with or without aspirin for primary prevention of cardiovascular disease
Autor: Mant, J, a další
Vydáno: (2021)

Role of aspirin in primary prevention of cardiovascular disease
Autor: Patrono, C, a další
Vydáno: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
Autor: VanWormer JJ, a další
Vydáno: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
Autor: Ying Xing, a další
Vydáno: (2019-07-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Vydáno: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Autor: Randall S Stafford, a další
Vydáno: (2005-12-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
Autor: Guillaume Marquis‐Gravel, a další
Vydáno: (2024-02-01)

An overview of the British and American aspirin studies.
Autor: Hennekens, C, a další
Vydáno: (1988)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
Autor: Hennekens, C, a další
Vydáno: (2006)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
Autor: L. O. Minushkina
Vydáno: (2017-12-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
Autor: Lozano R, a další
Vydáno: (2015-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
Autor: Yinong Chen, a další
Vydáno: (2021-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
Autor: Fernández-de-Bobadilla Jaime, a další
Vydáno: (2007-10-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
Autor: Sergio Coccheri
Vydáno: (2017-04-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
Autor: Caso, V, a další
Vydáno: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
Autor: Caso, V, a další
Vydáno: (2012)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
Autor: Mikkel B. Christensen, a další
Vydáno: (2021-06-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Autor: Price, H, a další
Vydáno: (2009)

Aspirin for prevention of cancer and cardiovascular disease.
Autor: Rose, P, a další
Vydáno: (2011)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
Autor: Patrono, C, a další
Vydáno: (2010)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
Autor: Nischal N Hegde, a další
Vydáno: (2023-01-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
Autor: Eleni Giannopoulou, a další
Vydáno: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
Autor: Athena L. Huang, a další
Vydáno: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
Autor: Athena L. Huang, MD, a další
Vydáno: (2023-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
Autor: N. В. Perepech, a další
Vydáno: (2018-05-01)

Antiplatelets in secondary stroke prevention
Autor: Olga eShulga, a další
Vydáno: (2011-07-01)

Antioxidant vitamins--benefits not yet proved.
Autor: Hennekens, C, a další
Vydáno: (1994)